Gene · 7079
Papers1,944
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,944
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring Genetic Drug Targets in Acne Vulgaris: A Comprehensive Proteome-Wide Mendelian Randomization Study. | J Cosmet Dermatol | 2024 | 39297226 | PubTator, text mining | PubMed |
| Threonine Deficiency Increases Triglyceride Deposition in Primary Duck Hepatocytes by Reducing STAT3 Phosphorylation. | Int J Mol Sci | 2024 | 39125712 | PubTator, text mining | PubMed |
| Identification of Novel Protein Biomarkers and Drug Targets for Acne Vulgaris by Integrating Human Plasma Proteome with Genome-Wide Association Data. | J Inflamm Res | 2024 | 39006495 | PubTator, text mining | PubMed |
| Differences in metalloproteinases and their tissue inhibitors in the cerebrospinal fluid are associated with delirium. | Commun Med (Lond) | 2024 | 38937571 | PubTator, text mining | PubMed |
| Altered brain expression and cerebrospinal fluid levels of TIMP4 in cerebral amyloid angiopathy. | Acta Neuropathol Commun | 2024 | 38915119 | PubTator, text mining | PubMed |
| Differential Inflammatory Responses in Adult and Pediatric COVID-19 Patients: Implications for Long-Term Consequences and Anti-Inflammatory Treatment. | Med Sci Monit | 2024 | 38816982 | PubTator, text mining | PubMed |
| Uncovering novel drug targets for bipolar disorder: a Mendelian randomization analysis of brain, cerebrospinal fluid, and plasma proteomes. | Psychol Med | 2024 | 38720515 | PubTator, text mining | PubMed |
| Potential therapeutic targets for membranous nephropathy: proteome-wide Mendelian randomization and colocalization analysis. | Front Immunol | 2024 | 38707900 | PubTator, text mining | PubMed |
| Biomarkers and Proteomics in Sarcomeric Hypertrophic Cardiomyopathy in the Young-FGF-21 Highly Associated with Overt Disease. | J Cardiovasc Dev Dis | 2024 | 38667723 | PubTator, text mining | PubMed |
| Dissecting the shared genetic landscape of anxiety, depression, and schizophrenia. | J Transl Med | 2024 | 38637810 | PubTator, text mining | PubMed |
| Comparison of Tissue Factors in the Ontogenetic Aspects of Human Cholesteatoma. | Diagnostics (Basel) | 2024 | 38535082 | PubTator, text mining | PubMed |
| Retrospective study on the short-term efficacy of different doses of Spironolactone in patients with heart failure of ischemic cardiomyopath and the influence of ventricular remodeling markers. | Am J Cardiovasc Dis | 2024 | 38495408 | PubTator, text mining | PubMed |
| Relationship between the Expression of Matrix Metalloproteinases and Their Tissue Inhibitors in Patients with Brain Tumors. | Int J Mol Sci | 2024 | 38474106 | PubTator, text mining | PubMed |
| Matrix metalloproteinases are associated with severity of disease among COVID-19 patients: A possible pharmacological target. | Basic Clin Pharmacol Toxicol | 2024 | 38468413 | PubTator, text mining | PubMed |
| Serum levels of matrix metalloproteinases 1, 2, and 7, and their tissue inhibitors 1, 2, 3, and 4 in polytraumatized patients: Time trajectories, correlations, and their ability to predict mortality. | PLoS One | 2024 | 38457458 | PubTator, text mining | PubMed |
| Expression of Tissue Inhibitors of Metalloproteinases (TIMP-1, TIMP-2, TIMP-3, TIMP-4) in Blood Serum of Patients with Keratoconus. | J Clin Med | 2024 | 38398480 | PubTator, text mining | PubMed |
| Calotropis procera: A double edged sword against glioblastoma, inhibiting glioblastoma cell line growth by targeting histone deacetylases (HDAC) and angiogenesis. | Heliyon | 2024 | 38304784 | PubTator, text mining | PubMed |
| Primary Peritoneal Serous Cancer: A Case Report of a Tumor in the Rectovaginal Septum. | Case Rep Oncol Med | 2024 | 38264474 | PubTator, text mining | PubMed |
| Targeted proteomics and metabolomics for biomarker discovery in abdominal aortic aneurysm and post-EVAR sac volume. | Clin Chim Acta | 2024 | 38246209 | PubTator, text mining | PubMed |
| Proteomic associations with forced expiratory volume: a Mendelian randomisation study. | Respir Res | 2024 | 38238732 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7079/papers?page=4